M
Maria Teresa Ambrosini
Researcher at University of Turin
Publications - 21
Citations - 1646
Maria Teresa Ambrosini is an academic researcher from University of Turin. The author has contributed to research in topics: Thalidomide & Melphalan. The author has an hindex of 11, co-authored 20 publications receiving 1612 citations.
Papers
More filters
Journal ArticleDOI
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
Antonio Palumbo,Sara Bringhen,Tommaso Caravita,Emanuela Merla,Vincenzo Capparella,Vincenzo Callea,Clotilde Cangialosi,Mariella Grasso,Fausto Rossini,Monica Galli,Lucio Catalano,Elena Zamagni,Maria Teresa Petrucci,Valerio De Stefano,Manuela Ceccarelli,Maria Teresa Ambrosini,Ilaria Avonto,Patrizia Falco,Giovannino Ciccone,Anna Marina Liberati,Pellegrino Musto,Mario Boccadoro +21 more
TL;DR: Oral MPT is an effective first-line treatment for elderly patients with multiple myeloma and anticoagulant prophylaxis reduces frequency of thrombosis.
Journal ArticleDOI
Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network
Antonio Palumbo,Patrizia Falco,Paolo Corradini,Antonietta Falcone,Francesco Di Raimondo,Nicola Giuliani,Claudia Crippa,Giovannino Ciccone,Paola Omedè,Maria Teresa Ambrosini,Sara Bringhen,Pellegrino Musto,Robin Foà,Rob Knight,Jerome B. Zeldis,Mario Boccadoro,Maria Teresa Petrucci +16 more
TL;DR: Oral MPR therapy is a promising first-line treatment for elderly myeloma patients and aspirin appears to provide adequate antithrombosis prophylaxis.
Journal ArticleDOI
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma
Antonio Palumbo,Maria Teresa Ambrosini,Giulia Benevolo,Patrizia Pregno,Norbert Pescosta,Vincenzo Callea,Clotilde Cangialosi,Tommaso Caravita,Fortunato Morabito,Pellegrino Musto,Sara Bringhen,Patrizia Falco,Ilaria Avonto,Federica Cavallo,Mario Boccadoro +14 more
TL;DR: In this paper, a multicenter phase 1/2 trial, dosing, safety and efficacy of the 4-drug combination, bortezomib, melphalan, prednisone, and thalidomide (VMPT) was determined.
Journal ArticleDOI
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates
Vittorio Montefusco,Francesco Spina,Rosalba Miceli,Massimo Maniezzo,Maria Teresa Ambrosini,Lucia Farina,Sheila Piva,Antonio Palumbo,Mario Boccadoro,Paolo Corradini +9 more
TL;DR: It is speculated that antibiotic prophylaxis before dental procedures may prevent ONJ occurrence after dental procedures, which had a protective effect.
Journal ArticleDOI
Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
Antonio Palumbo,Ilaria Avonto,Benedetto Bruno,Maria Teresa Ambrosini,Sara Bringhen,Federica Cavallo,Patrizia Falco,Mario Boccadoro +7 more
TL;DR: M(i.v.)PT is an effective regimen, which can overcome resistance to thalidomide plus prednisone in advanced myeloma with acceptable toxicity.